Delivery Order SPE2DB22D2206-SPE2DB23FKK60
- Not listed
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,755.14, is for the delivery of 4,563,750 units of 250 mg Cephalexin capsules. This is a firm fixed-price delivery order contract with a completion date of February 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,107.45, is for the supply of Cephalexin 500 mg capsules. This is a delivery order under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Cephalexin 500 mg capsules. The contract has a firm fixed price of $2,094.59 and a period of performance through July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The contract is not set aside and was awarded through open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,314,953 units of Cephalexin 500 mg capsules. The contract has a firm fixed price of $4,979.51 and a performance period that runs through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of 4,567,330,438 units of the drug Cephalexin 500 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $2,094.33, awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. There is no set-aside designation for this award. Amerisourcebergen holds a $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,609.79 to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,328.58 firm fixed-price delivery order is for the supply of Cephalexin 250 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 with the DLA Troop Support Medical. The IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,302.02 delivery order is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml containers. The contract has a firm fixed price and an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- This federal contract award, valued at $30,867.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563207552 - CEPHALEXIN 250 MG/5 ML SUSP 100ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FKK60Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,498.03, is a delivery order to provide 500 milligram cephalexin capsules to support federal healthcare programs. It is a firm fixed-price contract with a completion date of September 20, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 9/19/23 |